Encapsulation of PEGylated low-molecular-weight PEI polyplexes in hyaluronic acid hydrogels reduces aggregation.

Acta Biomater

Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA, USA. Electronic address:

Published: December 2015

AI Article Synopsis

  • Effective DNA delivery in gene therapy can be enhanced using porous hydrogel scaffolds that release DNA nanoparticles, which is important for tissue regeneration.
  • Two new methods were developed to reduce aggregation of DNA polyplexes in these hydrogels: one involves modifying the carrier polymer to lessen charge interactions, and the other uses electrostatic presentation of polyplexes on scaffold surfaces.
  • The modified polymer (sPEG-PEI) showed better properties, such as less toxicity and improved stability, while maintaining transfection abilities, indicating advancements in gene delivery techniques.

Article Abstract

Unlabelled: The effective delivery of DNA locally could increase the applicability of gene therapy in tissue regeneration and therapeutic angiogenesis. One promising approach is through use of porous hydrogel scaffolds that incorporate and deliver DNA in the form of nanoparticles to the affected sites. While we have previously reported on caged nanoparticle encapsulation (CnE) to load DNA polyplexes within hydrogels at high concentrations without aggregation, frequent issues with limited polyplex release following CnE have been encountered. In this study, we report two alternative approaches to polyplex presentation for decreasing aggregation in porous hydrogels. The first approach reduces polyplex aggregation by utilizing polyethylene glycol modification of the gene carrier polymer polyethyleneimine (sPEG-PEI) to mitigate charge-charge interactions between polyplexes and the scaffold during gelation. The second approach electrostatically presents polyplexes on the surfaces of scaffold pores as opposed to an encapsulated presentation. The sPEG-PEI polymer formed a smaller, less toxic, and more stable polyplex that exhibited less aggregation within HA gels when compared to the traditionally used linear PEI (LPEI) polymer. Surface-coated polyplexes also resulted in a more homogenous distribution of polyplexes in hydrogels. Furthermore, sPEG-PEI polyplexes retained transfection abilities comparable to LPEI in 3D surface-coated transfections. These results demonstrate a significant improvement in scaffold-mediated gene delivery and show promise in applications to multi-gene delivery systems.

Statement Of Significance: A promising gene delivery approach for regenerative medicine is implanting porous hydrogel scaffolds loaded with DNA nanoparticles for delivery to affected sites. However, loading DNA polyplexes at high concentrations within hydrogels results in significant aggregation. Here, we describe two methods for decreasing aggregation of DNA polyplexes in porous gels. First, the gene carrier polymer polyethyleneimine (PEI) was modified with polyethylene glycol (sPEG-PEI) to mitigate the electrostatic interactions between polyplexes and scaffold polymer to in turn decrease aggregation. Second, polyplexes were presented along the surfaces of the pores of the hydrogel instead of being encapsulated within the gel. These methods allow for highly tunable and sustained transgene expression from scaffold-mediated gene delivery while avoiding polyplex aggregation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648651PMC
http://dx.doi.org/10.1016/j.actbio.2015.09.020DOI Listing

Publication Analysis

Top Keywords

dna polyplexes
12
gene delivery
12
polyplexes
11
aggregation
9
porous hydrogel
8
hydrogel scaffolds
8
polyplexes hydrogels
8
high concentrations
8
decreasing aggregation
8
polyplex aggregation
8

Similar Publications

Article Synopsis
  • The study explores a new method for concentrating highly branched poly(β-amino ester) (HPAEs)/DNA nanoparticles for gene therapy aimed at treating cystic fibrosis, addressing challenges related to the high formulation concentrations required for clinical applications.
  • Researchers optimized a formulation using various buffers and achieved concentration through ultrafiltration, which significantly outperformed lyophilization by providing a 24-fold increase.
  • The concentrated formulation was effective in restoring CFTR protein production in lung epithelial cells, demonstrating better results than existing transfection reagents, highlighting its potential for future preclinical testing and clinical use.
View Article and Find Full Text PDF

Polyethylenimine (PEI) is a widely used cationic polymer for nonviral gene delivery, often modified to enhance transfection efficiency and reduce cytotoxicity. This study investigates how acetylation, succinylation (acPEI and zPEI), and pH influence the internal DNA packaging of polyplexes. Both modifications alter physicochemical properties, leading to complexes that decondense more readily with increasing modification.

View Article and Find Full Text PDF

Background: Poly (β-amino Ester) nanocarriers show promise for gene therapy, but their effectiveness can be limited by the environment within the body. This study aims to understand how common cell culture media components affect optimized PBAE nanocarrier performance in gene delivery.

Methods: Optimized PBAE was synthesized based on Michael addition reaction and characterized by different assays, this study employed techniques like DLS and TEM to characterize PBAE nanocarriers, followed by cellular uptake analysis (flow cytometry and confocal imaging) and evaluation of gene expression under different polymer/DNA ratio ratios and media conditions.

View Article and Find Full Text PDF

Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editing.

Eur J Pharm Sci

December 2024

Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität Munich, Butenandtstrasse 5-13, 81377 Munich, Germany; Center for Nanoscience (CeNS), LMU Munich, 80799 Munich, Germany; CNATM - Cluster for Nucleic Acid Therapeutics Munich, Germany. Electronic address:

Article Synopsis
  • CRISPR/Cas9 technology is a promising method for treating genetic diseases, but its effectiveness is limited by the availability of suitable delivery systems for the Cas9/sgRNA ribonucleoprotein (RNP).
  • This study explores dual pH-responsive amphiphilic xenopeptides (XPs) for delivering CRISPR/Cas9 RNP, demonstrating successful cellular uptake and genome editing in various cell lines, including a model for Duchenne muscular dystrophy (DMD).
  • Notably, modified xenopeptides increased gene editing efficiency, with some achieving an EC50 value as low as 0.51 nM, indicating improved potential for therapeutic applications.
View Article and Find Full Text PDF

Objectives: Breast cancer is the most common type of cancer among women and the second most common cause of death after lung cancer. The inhibitor of growth (ING) transcript levels are often suppressed in cancer cells, making it a promising candidate for cancer therapy. In this study, we aimed to formulate a polyplex that effectively carries and delivers pING4 to breast cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!